Elon Musk’s Business Empire Scores Benefits Under Trump Shake-Up
Government investigations into Mr. Musk’s companies are stalling from President Trump’s firings and Biden administration resignations.
Related Articles
Management of Coronary Stent Underexpansion:
AbstractCoronary stent underexpansion is an important problem and limitation of percutaneous coronary intervention, adversely affecting both short- and long-term patient outcomes. Stent underexpans…
Opinion | The Pharmaceutical Industry Heads Into Elon Musk’s Wood Chipper
Who needs N.I.H. grants? A lot of red-state universities, for one.
Sudden Cardiac Death in Childhood: Peaks in Teenagers | Circulation: Arrhythmia and Electrophysiology
Request permissions for this article. CRY Centre for Cardiovascular Pathology, Cardiovascular Clinical Academic Group and Cardiology Research Section, Cardiovascular and Genomics Research Institute, St George’s…
Opinion | The Doctor and the Pilot Who Saved the Eyesight of Millions
Seventy-five years ago, Harold Ridley successfully implanted the world’s first artificial intraocular lens.
Changes in the reactive hyperemia index after continuous and interval exercise – Daniel K Sweet, P Daniel Patterson, Steven Reis, Dave Hostler, 2024
Introduction: High-intensity interval exercise (HIIE) is more effective than moderate-intensity interval exercise (MICE) for improving macrovascular function (e…
Comparing Phenotypes for Acute and Long-Term Response to Atrial Fibrillation Ablation Using Machine Learning | Circulation: Arrhythmia and Electrophysiology
BACKGROUND: It is difficult to identify patients with atrial fibrillation (AF) most likely to respond to ablation. While any arrhythmia patient may recur after acutely…
The Texas Heart Institute Grand Rounds | Patrick T. O’Gara, MD, MACC, FAHA, FESC | 21st Century Challenges for the General Cardiologist
Patrick T. O’Gara, MD, MACC, FAHA, FESC Harvard Medical School Brigham and Women’s Hospital Boston, MA The Texas Heart Institute Grand Rounds is an esteemed…
Novartis to acquire drugmaker behind new heart therapy for up to $3.1B
The FDA has already shown great interest in the drug, which is designed to help AFib patients reduce their stroke and systemic embolism risks.
Aortic Stenosis With Dynamic Left Ventricular Outflow Obstruction: Diagnostic and Management Challenges—A Case Series
Although rare, aortic valve stenosis (AS) can coexist with hypertrophic cardiomyopathy (HCM) with obstruction. In an estimate from 207,880 patients from the National Inpatient Sample…
ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care
In the absence of full guidelines, this expert consensus decision pathway gives practical advice for clinicians.
